RxDoctor Payments Data

Talley Sofianos, PA

Medical · Daphne, ALNPI 1053652271

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 92.7% of the total across 164 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 19.1% — the pattern of someone who eats at a lot of different presentations.

$3,333in general payments, 2019–2025

Across 164 payments — averaging $20.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$638
  • AbbVie$535
  • LEO Pharma Inc.$381
  • Sun Pharmaceutical Industries Inc.$317
  • Lilly USA, LLC$221
  • Incyte Corporation$205
  • plus $1K from 15 others

What the payments were for

  • Food & beverage$3,08993%
  • Education$2447%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,333 in reported general payments places this provider in the 75th percentile of 175 medical providers in Alabama.

See all medical providers in Alabama

Medicare billing

Part B allowed, 2024
$46,176
Medicare patients
206
Services billed
2,277

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate49$2,231
Fluocinolone Acetonide15$1,061
Alclometasone Dipropionate23$925
Metronidazole15$864
Clindamycin Phosphate17$818
Triamcinolone Acetonide37$579
Ketoconazole29$573
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc27$453
Doxycycline Hyclate26$411
Pentoxifylline11$393
Ammonium Lactate23$384
Minocycline Hcl14$356
Fluconazole24$202
Mupirocin19$136
Levocetirizine Dihydrochloride14$112

Paid to pharmacies, not to this prescriber.

Other medical in Daphne

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →